| Trial ID: | L6538 |
| Source ID: | NCT01758471
|
| Associated Drug: |
Glipizide
|
| Title: |
Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glipizide|DRUG: Acarbose
|
| Outcome Measures: |
Primary: euglycemia, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
160
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-12
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-01
|
| Locations: |
Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases, Shanghai, Shanghai, 200025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01758471
|
